Alpha-mercaptoacrylic acid derivatives as novel selective calpain inhibitors.
Wang
K K
KK
Department of Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
Posner
A
A
Raser
K J
KJ
Buroker-Kilgore
M
M
Nath
R
R
Hajimohammadreza
I
I
Probert
A W
AW
Marcoux
F W
FW
Lunney
E A
EA
Hays
S J
SJ
Yuen P-W
D000179:Acrylates / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D002154:Calpain / Q000037:antagonists & inhibitors*; D002463:Cell Membrane Permeability; D015853:Cysteine Proteinase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D018696:Neuroprotective Agents / Q000493:pharmacokinetics / Q000494:pharmacology
D000179:Acrylates; D015853:Cysteine Proteinase Inhibitors; D018696:Neuroprotective Agents; C100442:PD 150606; D002154:Calpain